By Marie Rosenthal, MS
The “kick and kill” strategy was not more effective in controlling viral load than standard antiretroviral therapy (ART), according to the first randomized clinical trial to test the novel approach, which involves activating latent HIV and then killing the viral reservoirs, according to a presentation at the International AIDS Conference (AIDS 2018).
The RIVER study, a proof-of-concept trial that ran from 2015 to 2018 in London and Brighton, England, examined